Britain's GSK and China's Jiangsu Hengrui Pharmaceuticals have agreed on a $500 million deal to develop up to a dozen new ...

Shares of GSK fell to below $30 around the time of the demerger, but have since recovered to about $36. The 20% gain over 34 ...

The star of GSK’s Hengrui partnership is the COPD candidate HRS-9821, which will complement the pharma’s respiratory pipeline ...

CEO Emma Walmsley’s 40-bln-pound 2031 sales target looks fanciful after another disappointing drug trial. A healthy balance ...

School vaccine exemptions: What to know Exceptions and exemptions to required vaccines in Kentucky are explained under section three of 902 KAR 2.060.

GSK ’s shingles vaccine Shingrix will make its debut in a new prefilled syringe after snagging FDA approval, offering a more convenient administration process.